ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Hyperthermia malignant,Body temperature altered,Body temperature conditions,Genrl,Y
2,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,Y
3,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
4,1,Peripheral embolism,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
5,1,Peripheral embolism,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
6,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
6,2,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
6,3,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
6,4,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
6,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
7,2,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
8,1,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
9,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
10,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
10,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
10,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
10,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
10,5,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
10,6,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
11,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11,2,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
12,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
13,1,Seroma,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
13,2,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
14,1,Seroma,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
15,1,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
16,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
17,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
18,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
18,2,Dyschromatopsia,Colour blindness (incl acquired),Vision disorders,Eye,N
18,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
18,4,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
19,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
19,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
20,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
20,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
21,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
21,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
22,1,Air embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,Y
22,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
22,3,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
22,4,Pulseless electrical activity,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
23,1,Soft tissue necrosis,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
23,2,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
24,1,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
24,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
25,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
25,2,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
25,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
25,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
25,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
25,6,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
25,7,Subdural hygroma,Structural brain disorders NEC,Structural brain disorders,Nerv,N
26,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
26,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
26,3,Subdural hygroma,Structural brain disorders NEC,Structural brain disorders,Nerv,N
27,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
27,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
28,1,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
28,2,Streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
28,3,Telangiectasia,Telangiectasia and related conditions,Skin vascular abnormalities,Skin,N
28,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
29,1,Infected seroma,Infections NEC,Infections - pathogen unspecified,Infec,N
29,2,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
30,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
30,2,Infected seroma,Infections NEC,Infections - pathogen unspecified,Infec,N
30,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
30,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
30,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
30,6,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
30,7,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
31,1,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
32,1,Cerebrospinal fluid leakage,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
32,2,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
32,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
33,1,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
33,2,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
33,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
33,4,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
34,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
35,1,Wound abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
35,2,Wound decomposition,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
36,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
36,2,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
36,3,Seroma,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
37,1,Wound necrosis,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
38,1,Infected seroma,Infections NEC,Infections - pathogen unspecified,Infec,N
38,2,Procedural complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
38,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
39,1,Cerebrospinal fluid leakage,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
39,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
39,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
40,1,Cerebrospinal fluid leakage,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
40,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
40,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
41,1,Cerebrospinal fluid leakage,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
41,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
41,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
42,1,Exophthalmos,"Structural change, deposit and degeneration of eye NEC","Ocular structural change, deposit and degeneration NEC",Eye,N
42,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
42,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
43,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
44,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
45,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
46,1,Muscle tightness,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
46,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
46,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
47,1,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
48,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
49,1,Foreign body in reproductive tract,Reproductive system and breast injuries,Injuries NEC,Inj&P,N
49,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
50,1,Anal hypoaesthesia,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
50,2,Cauda equina syndrome,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
50,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
50,4,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
